Financial reports
10-K
2023 FY
Annual report
15 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
24 Feb 22
Current reports
8-K
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
15 Feb 24
8-K
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
8 Jan 24
8-K
Agios Reports Business Highlights and Third Quarter 2023 Financial Results
2 Nov 23
8-K
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
3 Aug 23
8-K
Departure of Directors or Certain Officers
14 Jun 23
8-K
Departure of Directors or Certain Officers
25 May 23
8-K
Agios Reports Business Highlights and First Quarter 2023 Financial Results
4 May 23
8-K
Departure of Directors or Certain Officers
19 Apr 23
8-K
Amendments to Articles of Incorporation or Bylaws
3 Mar 23
8-K
Agios Reports Fourth Quarter and Full Year 2022 Financial Results
23 Feb 23
Registration and prospectus
S-8
Registration of securities for employees
13 Jun 23
S-8
Registration of securities for employees
23 Feb 23
S-3ASR
Automatic shelf registration
23 Feb 23
S-8
Registration of securities for employees
3 Jan 23
S-8
Registration of securities for employees
26 Sep 22
S-8
Registration of securities for employees
8 Aug 22
S-8
Registration of securities for employees
24 Feb 22
S-8
Registration of securities for employees
25 Feb 21
S-3ASR
Automatic shelf registration
30 Apr 20
POSASR
Automatic shelf registration (post-effective amendment)
30 Apr 20
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
10 May 21
DEFA14A
Additional proxy soliciting materials
8 Apr 21
DEF 14A
Definitive proxy
8 Apr 21
DEFA14A
Additional proxy soliciting materials
15 Mar 21
DEFM14A
Proxy related to merger
11 Feb 21
PREM14A
Preliminary proxy related to merger
29 Jan 21
Other
CT ORDER
Confidential treatment order
10 Sep 21
CT ORDER
Confidential treatment order
16 Jul 19
CT ORDER
Confidential treatment order
26 Apr 19
CT ORDER
Confidential treatment order
26 Apr 19
CT ORDER
Confidential treatment order
24 Aug 18
CT ORDER
Confidential treatment order
21 Aug 18
UPLOAD
Letter from SEC
30 Jul 18
CORRESP
Correspondence with SEC
13 Jul 18
UPLOAD
Letter from SEC
3 Jul 18
UPLOAD
Letter from SEC
21 Aug 17
Ownership
4
JACQUALYN A FOUSE
10 Apr 24
4
Kaye I Foster-Cheek
11 Mar 24
4
Kaye I Foster-Cheek
7 Mar 24
4
Theodore James Jr. Washburn
7 Mar 24
144
Notice of proposed sale of securities
7 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
4
Sarah Gheuens
5 Mar 24
4
Cecilia Jones
5 Mar 24
4
Theodore James Jr. Washburn
5 Mar 24